A 60 Minutes segment Sunday on Anil Potti has drawn national attention to the case, so we thought this would be a good time to compile all of the retractions and corrections in one place. Duke has said that about a third of Potti’s 40-some-odd papers would be retracted, and another third would have “a … Continue reading The Anil Potti retraction record so far
Anil Potti can add two corrections to his less-and-less impressive publication record. The mega-corrections — part of what we are close to being ready to call a trend in errata notices — in the Journal of Clinical Oncology (JCO) are, however, quite impressive, each with at least a dozen points. One of the corrections, for … Continue reading Two mega-corrections for Anil Potti in the Journal of Clinical Oncology
Former Duke oncology researcher Anil Potti has retracted another paper, marking his ninth withdrawal. The notice in the Journal of Clinical Oncology (JCO) reads: “An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer” by Holly K. Dressman, Andrew Berchuck, Gina Chan, Jun Zhai, Andrea Bild, Robyn Sayer, Janiel Cragun, Jennifer Clarke, … Continue reading Anil Potti and colleagues retract ninth paper, this one in JCO
“Neither snow nor rain nor heat nor gloom of night” keeps U.S. mail carriers from delivering your letters and packages, and neither seven retractions, nor being forced to resign, nor malpractice settlements (and an ongoing case) keeps former Duke oncologist Anil Potti from publishing papers. Potti’s latest effort, “A Pathway-Based Approach to Identify Molecular Biomarkers in … Continue reading Seven retractions, a resignation, and lawsuit settlements haven’t stopped Anil Potti from publishing
There are a few new developments in the case of Anil Potti, the former Duke oncologist who resigned amidst an investigation into clinical trials he was running — and has been forced to retract seven papers, at last count. Over the weekend, The Cancer Letter, which has been out front on this case, noted that … Continue reading Anil Potti reprimanded by North Carolina state medical board, as lawsuit settlements surface
Anil Potti, the former cancer researcher whose work has become the subject of intense scrutiny that has already led to the retraction of five papers, didn’t tell the Journal of the American Medical Association (JAMA) about two very relevant corporate relationships he had when he published papers there, Retraction Watch has learned. JAMA has published two papers by … Continue reading Anil Potti failed to disclose corporate ties in yet-to-be-retracted JAMA papers
Anil Potti, the oncologist who has been forced to retract four papers because of results that could not be reproduced, and resigned last fall from Duke, has a new job. He’s joined the Coastal Cancer Center, an oncology practice with four offices in South Carolina and one in North Carolina. The Duke Fact Checker was … Continue reading Anil Potti resurfaces at South Carolina cancer center
For those Retraction Watch readers who have been following the case of Anil Potti — who has now retracted four papers — Keith Baggerly’s name will likely be familiar. Baggerly is the bioinformatician at M.D. Anderson in Houston who has been publicly questioning, in letters, papers, and The Cancer Letter, work by Potti et. al. … Continue reading The Importance of Being Reproducible: Keith Baggerly tells the Anil Potti story
Early in December, as the house of cards that is Anil Potti‘s publication record started to really collapse, we called attention to a paper in The Lancet Oncology that had already been the subject of a correction and Expression of Concern in July of last year. Today, the journal officially retracted the paper, “Validation of … Continue reading Lancet Oncology retracts previously questioned Anil Potti paper
Nature Medicine has retracted a paper that Anil Potti’s co-author, Joseph Nevins, requested be withdrawn in November. This is the second retraction of a paper by Potti, who resigned from his post at Duke in November in the midst of an investigation into scientific misconduct. The first retraction was in the Journal of Clinical … Continue reading Nature Medicine makes it official, retracting Anil Potti paper